nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers
|
Kang, Lihua |
|
2015 |
51 |
2 |
p. 260-270 11 p. |
artikel |
2 |
ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth
|
Dhyani, Anamika |
|
2015 |
51 |
2 |
p. 252-259 8 p. |
artikel |
3 |
Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma
|
Hokuto, Daisuke |
|
2015 |
51 |
2 |
p. 157-165 9 p. |
artikel |
4 |
Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysis
|
Taieb, Sophie |
|
2015 |
51 |
2 |
p. 202-209 8 p. |
artikel |
5 |
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer
|
Vassal, Gilles |
|
2015 |
51 |
2 |
p. 218-224 7 p. |
artikel |
6 |
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
|
Ben Arush, M. |
|
2015 |
51 |
2 |
p. 193-201 9 p. |
artikel |
7 |
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials
|
Faron, Matthieu |
|
2015 |
51 |
2 |
p. 166-176 11 p. |
artikel |
8 |
Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients’ and professionals’ expertise – A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative
|
Kasper, B. |
|
2015 |
51 |
2 |
p. 127-136 10 p. |
artikel |
9 |
Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centre
|
Khoja, L. |
|
2015 |
51 |
2 |
p. 233-240 8 p. |
artikel |
10 |
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
|
Spicer, J. |
|
2015 |
51 |
2 |
p. 137-145 9 p. |
artikel |
11 |
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
|
Weihrauch, Martin R. |
|
2015 |
51 |
2 |
p. 146-156 11 p. |
artikel |
12 |
Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer
|
Kwon, Minsu |
|
2015 |
51 |
2 |
p. 177-185 9 p. |
artikel |
13 |
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy – The United Kingdom experience
|
Irtan, S. |
|
2015 |
51 |
2 |
p. 225-232 8 p. |
artikel |
14 |
Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients
|
Colombo, C. |
|
2015 |
51 |
2 |
p. 186-192 7 p. |
artikel |
15 |
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors
|
Palmerini, Emanuela |
|
2015 |
51 |
2 |
p. 210-217 8 p. |
artikel |
16 |
Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries
|
Anttila, Ahti |
|
2015 |
51 |
2 |
p. 241-251 11 p. |
artikel |